Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ABAX --- lots of upside -- Ignore unavailable to you. Want to Upgrade?

To: burner who wrote (365)	11/16/1997 7:15:00 PM
From: Yo Yo	Read Replies (1) \| Respond to of 492

Have looked at many charts of many financial aspects of ABAX. The bottom line is that their gross margins are really poor. ABAX has to improve them. To paraphrase James Carville(sp?).... It's the disks, stupid! They have got to improve margins on the disks, they have to get to automated manufacturing, then things will look better. How soon can they do it? Analyzers are still 60% of revenues and will be significant for some time. I doubt they will ever make much on them. The past don't mean a thing. The next quarter does not look good for analyzer sales. Round one of Navy purchases is over, Mexico order has shipped, initial stocking in Japan is done, veteranary market filling up, no big orders announced. How many analyzers will they sell? It could be less than this quarter. Anyone else have any thoughts?